Page 3 - Merck

Merck zooms 19% on open offer by Procter & Gamble Overseas India

The stock surged 19% to Rs 1,795, also its record high on the BSE after the Procter & Gamble Overseas India makes mandatory open offer at price of Rs 1,500.36 per share

Merck expects strong growth from India, says executive board member

The life science division which manufactures laboratory materials, chemicals and is the largest of its segment in India

Merck may sell consumer health business to focus on new drugs

is exploring sale or strategic partnership for its consumer health business including India as it continues focus to develop innovative drugs.The plan to hive off consumer health business is second such move by the drug maker which sold its biosimilar business to Fresenius earlier this year.The German drug maker Merck KGaA operates in 66 countries and its business is spread across pharmaceuticals, laboratory solutions, chemicals and liquid crystals. In 2016 the company had global sales of over 15 billion Euros. Consumer health contributed to 850 million Euros.Merck, which has been present in India for over five decades, operates through five main companies including its listed entity Merck Limited. Merck did not respond to an email query and did not share the most recent consumer health sales figures for India. Merck Ltd 2015 annual report shows the business contributed over Rs 200 crore or around 24 per cent of its Rs 904 crore sales (the company follows January-December ...

Merck opens first India M Lab in Bengaluru to help biopharma firms scale

Lab will also help with technology absorption, making drugs for clinical trials and regulatory nods

Merck hits 52-week high as Q3 profit doubles

The stock rallied 13% to Rs 906 in intra-day after reported profit of Rs 27.54 crore in Q3CY16 against Rs 12.51 crore in the same quarter last year.